Vivo Bio Tech (BOM:511509) Other Current Payables: ₹0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:511509 Vivo Bio Tech Ltd BOM:511509
63 GF Score
Price ₹22.96
GF Value ₹30.40
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Vivo Bio Tech Other Current Payables?

Vivo Bio Tech BOM:511509 -0.26% 63 Other Current Payables is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:511509 with a GF Score™ of 63/100 and a GF Value™ of ₹30.40 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Vivo Bio Tech's Other Current Payables for the quarter that ended in Jun. 2026 was ₹0.0 Mil.

Vivo Bio Tech's annual Other Current Payables increased from Mar. 2024 (₹28.8 Mil) to Mar. 2025 (₹32.2 Mil) but then declined from Mar. 2025 (₹32.2 Mil) to Mar. 2026 (₹0.0 Mil).

Vivo Bio Tech Other Current Payables Related Terms

Vivo Bio Tech Other Current Payables Historical Data

* Premium members only.

The historical data trend for Vivo Bio Tech's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivo Bio Tech Other Current Payables Chart

Vivo Bio Tech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.95 29.19 28.83 32.17 0.00

Vivo Bio Tech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:511509
63GF Score
Vivo Bio Tech Ltd BOM:511509
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivo Bio Tech Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ₹0.0 Mil mean?
Vivo Bio Tech (BOM:511509) has a Other Current Payables of ₹0.0 Mil as of Jun. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Vivo Bio Tech and its competitors.
Is Vivo Bio Tech's Other Current Payables too high?
Vivo Bio Tech's current Other Current Payables is ₹0.0 Mil. Overall, Vivo Bio Tech has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vivo Bio Tech's Other Current Payables compare to VRTX and REGN?
Vivo Bio Tech's Other Current Payables of ₹0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Vivo Bio Tech and its competitors. Vivo Bio Tech's current Other Current Payables is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivo Bio Tech stock overvalued right now?
Based on GuruFocus' analysis, Vivo Bio Tech (BOM:511509) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹30.40, compared to a current price of ₹22.96 — trading 24.5% below its estimated fair value. The current Other Current Payables is ₹0.0 Mil. Vivo Bio Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Vivo Bio Tech (BOM:511509), the current Other Current Payables is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vivo Bio Tech (BOM:511509) Overvalued in 2026?

Based on GuruFocus' analysis, Vivo Bio Tech stock appears to be undervalued. The current stock price of ₹22.96 is trading 24.5% below its estimated GF Value™ of ₹30.40. GuruFocus considers Vivo Bio Tech to be Modestly Undervalued.

Key valuation signals for BOM:511509:

  • Other Current Payables: ₹0.0 Mil
  • GF Value™: ₹30.40 vs. price of ₹22.96 (24.5% below fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the BOM:511509 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vivo Bio Tech Business Description

Address Number 8-2-672/ 5 & 6, Road Number 1, 3rd Floor, Ilyas Mohammed Khan Estate, Banjara hills, Hyderabad, TG, IND, 500034
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.
63GF Score

Get the complete analysis for BOM:511509

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹22.96
Price
₹30.40
GF Value